Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
89.5 CHF | -0.56% | +4.64% | +5.46% |
Apr. 26 | NOVARTIS AG : Receives a Buy rating from Jefferies | ZD |
Apr. 24 | BMO Capital Adjusts Price Target on Novartis to $116 From $114, Maintains Market Perform Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.46% | 201B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
-9.61% | 193B | |
-6.26% | 144B | |
-11.77% | 143B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis' : Kesimpta Shows Stable Antibody Levels in Patients of Phase 3b Extension Study